ClinVar Miner

Submissions for variant NM_000138.5(FBN1):c.5776_5778del (p.Asn1926del)

gnomAD frequency: 0.00001  dbSNP: rs886038964
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001525147 SCV000319365 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2019-02-26 criteria provided, single submitter clinical testing The c.5776_5778delAAT variant (also known as p.N1926del) is located in coding exon 46 of the FBN1 gene. This variant results from an in-frame deletion of 3 nucleotides at positions 5776 to 5778, causing the removal of a well-conserved asparagine residue at codon 1926. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Color Diagnostics, LLC DBA Color Health RCV001525147 SCV001735189 uncertain significance Familial thoracic aortic aneurysm and aortic dissection 2023-11-03 criteria provided, single submitter clinical testing This variant causes a deletion of asparagine at codon 1926 of the FBN1 protein. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with FBN1-related disorders in the literature. This variant has been identified in 1/251088 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Labcorp Genetics (formerly Invitae), Labcorp RCV001854976 SCV002189863 uncertain significance Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection 2023-09-10 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 263883). This variant has not been reported in the literature in individuals affected with FBN1-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This variant, c.5776_5778del, results in the deletion of 1 amino acid(s) of the FBN1 protein (p.Asn1926del), but otherwise preserves the integrity of the reading frame.
Fulgent Genetics, Fulgent Genetics RCV002487144 SCV002776455 uncertain significance Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome 2021-11-10 criteria provided, single submitter clinical testing
All of Us Research Program, National Institutes of Health RCV003995697 SCV004814630 uncertain significance Marfan syndrome 2023-12-13 criteria provided, single submitter clinical testing This variant causes an in-frame deletion of one amino acid of the FBN1 protein. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 1/251088 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
GeneDx RCV004777643 SCV005390686 uncertain significance not provided 2024-03-19 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In-frame deletion of 1 amino acid in a non-repeat region; In silico analysis supports a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 12938084, 31506931)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.